Style | Citing Format |
---|---|
MLA | Ghorbani M, et al.. "Flot (A Chemotherapy Regimen for Gastric/Esophagogastric Junction Cancer): To Be Treated As a Highly Emetogenic Regimen or a Moderately Emetogenic One? Comparison of the Emetogenic Potential of Flot Versus Folfox and Tac Regimens." Supportive Care in Cancer, vol. 30, no. 5, 2022, pp. 3865-3873. |
APA | Ghorbani M, Dehghani M, Fahimfar N, Namazi S, Dehshahri A (2022). Flot (A Chemotherapy Regimen for Gastric/Esophagogastric Junction Cancer): To Be Treated As a Highly Emetogenic Regimen or a Moderately Emetogenic One? Comparison of the Emetogenic Potential of Flot Versus Folfox and Tac Regimens. Supportive Care in Cancer, 30(5), 3865-3873. |
Chicago | Ghorbani M, Dehghani M, Fahimfar N, Namazi S, Dehshahri A. "Flot (A Chemotherapy Regimen for Gastric/Esophagogastric Junction Cancer): To Be Treated As a Highly Emetogenic Regimen or a Moderately Emetogenic One? Comparison of the Emetogenic Potential of Flot Versus Folfox and Tac Regimens." Supportive Care in Cancer 30, no. 5 (2022): 3865-3873. |
Harvard | Ghorbani M et al. (2022) 'Flot (A Chemotherapy Regimen for Gastric/Esophagogastric Junction Cancer): To Be Treated As a Highly Emetogenic Regimen or a Moderately Emetogenic One? Comparison of the Emetogenic Potential of Flot Versus Folfox and Tac Regimens', Supportive Care in Cancer, 30(5), pp. 3865-3873. |
Vancouver | Ghorbani M, Dehghani M, Fahimfar N, Namazi S, Dehshahri A. Flot (A Chemotherapy Regimen for Gastric/Esophagogastric Junction Cancer): To Be Treated As a Highly Emetogenic Regimen or a Moderately Emetogenic One? Comparison of the Emetogenic Potential of Flot Versus Folfox and Tac Regimens. Supportive Care in Cancer. 2022;30(5):3865-3873. |
BibTex | @article{ author = {Ghorbani M and Dehghani M and Fahimfar N and Namazi S and Dehshahri A}, title = {Flot (A Chemotherapy Regimen for Gastric/Esophagogastric Junction Cancer): To Be Treated As a Highly Emetogenic Regimen or a Moderately Emetogenic One? Comparison of the Emetogenic Potential of Flot Versus Folfox and Tac Regimens}, journal = {Supportive Care in Cancer}, volume = {30}, number = {5}, pages = {3865-3873}, year = {2022} } |
RIS | TY - JOUR AU - Ghorbani M AU - Dehghani M AU - Fahimfar N AU - Namazi S AU - Dehshahri A TI - Flot (A Chemotherapy Regimen for Gastric/Esophagogastric Junction Cancer): To Be Treated As a Highly Emetogenic Regimen or a Moderately Emetogenic One? Comparison of the Emetogenic Potential of Flot Versus Folfox and Tac Regimens JO - Supportive Care in Cancer VL - 30 IS - 5 SP - 3865 EP - 3873 PY - 2022 ER - |